Wegovy Cost and Coupons in 2026: What Drives the Number

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

"How much does Wegovy cost, and are there coupons?" is one of the most-searched GLP-1 questions, and the real answer depends on several moving parts. Out-of-pocket cost turns on insurance coverage, the indication on the prescription, savings-card eligibility, pharmacy pricing, and whether a compounded alternative applies. This guide walks through each factually. Start at our Education Hub for related reading.

Wegovy list price in 2026

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). But list price is rarely what most insured patients pay — it is the starting point before insurance, rebates, savings cards, and pharmacy negotiation. What you actually pay at the counter can differ substantially from that headline number.

Insurance and prior authorization

Commercial coverage of Wegovy depends on whether the prescription is written for an FDA-approved indication and on the plan's formulary and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes. Coverage for chronic weight management varies more widely, is often subject to BMI-based prior authorization, and some plans exclude weight-management indications entirely. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products.

Savings cards and coupons

Novo Nordisk publishes a manufacturer savings-card program that, for eligible commercially-insured patients, can substantially reduce monthly out-of-pocket cost. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and the cards carry monthly and annual caps. Independent discount platforms such as GoodRx and SingleCare also publish coupon prices that vary by pharmacy.

What real scenarios look like

With commercial insurance that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps. Without coverage of the indication, cash-pay costs move closer to list price minus any coupon. Without insurance, cash-pay approaches list price.

Compounded alternatives and what changed

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing the window without eliminating all legitimate activity. Compounded products are not identical to brand products and are priced separately. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — including Semaglutide Injection and Tirzepatide Injection — with per-protocol pricing published on each product page.

The genetic context upstream

What distinguishes the PlexusDx approach is starting with the biology. Before any GLP-1 protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including variants in MC4R, FTO that shape your baseline appetite-regulation and energy-balance biology. It does not predict response to any specific medication; it supports an informed conversation with your provider.

Why the counter price can surprise you

Many people are caught off guard at the pharmacy because they anchored to a number that did not match their situation — a list price, a coupon meant for a different scenario, or a savings-card figure they were not eligible for. The gap between a headline price and the counter price is almost always explained by insurance status, the indication on the prescription, and eligibility rules.

The practical takeaway is to confirm the specifics before you fill. Ask the pharmacy what your actual out-of-pocket cost will be, check savings-card terms directly with the manufacturer, and understand whether your plan covers the indication written. Doing that homework converts a frustrating surprise into a predictable number, and it lets you weigh brand and compounded options on a genuine, like-for-like basis rather than a misleading one.

Approached this way, Wegovy's cost becomes a solvable puzzle rather than a moving target. The list price is only the headline; your actual number depends on facts you can confirm in advance. Whether you ultimately consider a brand product or a compounded alternative, understanding those drivers — and the genetic context upstream of any protocol — lets you make the decision on clear terms.

Frequently Asked Questions

How much does Wegovy cost per month?

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). Insurance, savings cards, and pharmacy pricing can substantially change what a patient actually pays at the counter. Verify the current price with the pharmacy before fill.

Does insurance cover Wegovy?

Coverage depends on the plan, formulary, FDA indication on the prescription, and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes; chronic weight-management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there coupons or savings cards for Wegovy?

Novo Nordisk publishes a manufacturer savings-card program for commercially-insured patients who meet eligibility criteria. Independent platforms like GoodRx also publish discount prices. Government-insurance patients are typically excluded from manufacturer cards. Check the manufacturer site at the time of fill for current terms.

Are there lower-cost alternatives to Wegovy?

Licensed compounding pharmacies produce compounded semaglutide and tirzepatide at separate price points from brand products. Compounded products are legally and factually different — not identical, not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with published per-protocol pricing on each product page.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.